13F Holdings
中文EN

XAIR Beyond Air, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1641631 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY41.2%
TTM net income YoY9.1%
TTM EPS YoY168.8%
Revenue 3-yr CAGR201.8%
Net income 3-yr CAGR—

Margins

Gross margin10.0%
Operating margin-321.7%
Net margin-407.3%
FCF margin-259.0%
EBITDA margin-282.6%

Returns

ROE-369.6%
ROA-99.3%
ROIC (approx.)-1,404.8%
Asset turnover0.24x

Leverage & solvency

Liabilities / assets83.1%
Debt / equity0.00x
Current ratio3.67x
Interest coverage-4.95x

Cash quality & payout

Operating cash flow / net income0.59x
Accruals ratio-40.7%
Payout ratio—
Capex / revenue18.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-03-31FY20252025-03-31FY20242024-03-31FY2023*2023-03-31FY20222022-03-31
Income statement
Revenue$7.68M$3.71M$1.16M$0—
Cost of revenue$7.43M$5.37M$2.47M$555,000—
Gross profit$252,000-$1.66M-$1.31M-$555,000—
R&D expense$10.24M$16.86M$24.36M$16.81M$11.80M
SG&A expense$19.05M$26.02M$37.34M$34.69M$18.41M
Operating income-$29.04M-$44.54M-$63.01M-$52.06M-$40.71M
Interest expense$3.52M$3.02M$2.91M$30,000$775,000
Pretax income-$34.33M-$48.48M-$64.30M-$59.40M-$44.06M
Net income-$33.25M-$46.62M-$60.24M-$55.82M-$43.18M
EBITDA-$25.94M-$41.54M-$61.21M-$51.46M-$40.40M
EPS (basic)-4.01-13.77-1.82-1.86-1.68
EPS (diluted)-4.01-13.77-1.82-1.86—
Weighted avg. shares (diluted)8.30M3.39M33.16M29.97M—
Balance sheet
Cash & equivalents$6.74M$4.67M$11.38M$29.16M$80.24M
Short-term investments$4.90M$2.25M$23.09M$16.72M—
Receivables$1.09M$710,000$319,000$420,000$322,000
Inventory$1.41M$2.42M$2.13M$1.13M$350,000
Current assets$24.77M$16.02M$43.94M$59.41M$92.94M
PP&E, net$8.25M$11.01M$9.36M$5.00M$2.00M
Intangibles$1.02M$1.22M$1.43M$1.63M$1.84M
Total assets$35.38M$30.06M$56.96M$68.75M$99.20M
Current liabilities$6.51M$5.00M$11.57M$19.78M$10.71M
Long-term debt——$17.50M$200,000$200,000
Total debt——$17.50M$200,000$200,000
Total liabilities$29.18M$15.72M$29.77M$26.72M$20.99M
Shareholders' equity$6.13M$13.58M$25.05M$37.91M$72.70M
Net debt——$6.12M-$28.96M-$80.04M
Shares outstanding589,6394.13M45.90M30.74M29.89M
Cash flow statement
Operating cash flow-$18.14M-$38.22M-$56.01M-$33.01M-$23.13M
Capital expenditure$1.02M$5.88M$5.75M$3.88M$1.38M
Free cash flow-$19.17M-$44.10M-$61.76M-$36.89M-$24.51M
Investing cash flow-$3.67M$14.90M-$12.23M-$20.59M-$1.45M
Financing cash flow$29.09M$16.65M$43.17M$2.70M$79.45M
Depreciation & amortization$3.10M$3.00M$1.80M$600,000$314,000
Stock-based compensation$5.28M$9.15M$21.34M$19.56M$7.83M

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.